http://oldabcuro.golins.com/abcuro_pubs/greenberg-et-al-highly-differentiated-cytotoxic-t-cells-in-inclusion-body-myositis-brain-2019-sep-114292590-2604/ 2022-09-07T15:07:45+00:00 http://oldabcuro.golins.com/abcuro_pubs/greenberg-inclusion-body-myositis-clinical-features-and-pathogenesis-nat-rev-rheumatol-2019-may155257-272/ 2022-09-07T15:09:39+00:00 http://oldabcuro.golins.com/abcuro_pubs/greenberg-et-al-association-of-inclusion-body-myositis-with-t-cell-large-granular-lymphocytic-leukaemia-brain-2016-may139pt-51348-60/ 2022-09-07T19:19:03+00:00 http://oldabcuro.golins.com/abcuro_pubs/epidemiology-and-patient-journey-in-inclusion-body-myositis-a-machine-learning-methodology-applied-to-claims-data-in-the-united-states/ 2025-04-09T22:43:25+00:00 http://oldabcuro.golins.com/abcuro_pubs/pharmacokinetics-pharmacodynamics-and-safety-profile-of-ulviprubart-results-from-a-48-week-open-label-phase-1-study-in-patients-with-inclusion-body-myositis/ 2025-04-09T22:43:40+00:00 http://oldabcuro.golins.com/abcuro_pubs/ulviprubart-pharmacokinetics-pharmacodynamics-and-safety-phase-1-study-results-in-patients-with-inclusion-body-myositis/ 2025-06-14T13:24:32+00:00 http://oldabcuro.golins.com/abcuro_pubs/ulviprubart-pharmacokinetics-pharmacodynamics-and-safety-phase-1-study-results-in-patients-with-inclusion-body-myositis-2/ 2025-10-11T13:00:43+00:00 http://oldabcuro.golins.com/abcuro_pubs/phase-2-3-study-of-ulviprubart-in-inclusion-body-myositis-study-design-patient-characteristics-and-topline-results-2/ 2026-05-04T15:08:48+00:00 http://oldabcuro.golins.com/abcuro_pubs/patient-journey-healthcare-resource-utilization-and-mortality-in-ibm-a-us-based-claims-analysis/ 2026-05-04T15:10:31+00:00 http://oldabcuro.golins.com/abcuro_pubs/phase-2-3-study-of-ulviprubart-in-inclusion-body-myositis-study-design-patient-characteristics-and-topline-results/ 2026-05-04T15:10:47+00:00 http://oldabcuro.golins.com/abcuro_pubs/selective-depletion-of-klrg1-t-cells-in-a-first-in-human-clinical-trial-of-abc008-in-inclusion-body-myositis-ibm-gcom-2022-poster/ 2026-05-04T15:11:28+00:00 http://oldabcuro.golins.com/abcuro_pubs/goel-et-al-depletion-of-klrg1-t-cells-in-a-first-in-human-clinical-trial-of-abc008-in-inclusion-body-myositis-ibm-acr-2021-poster/ 2026-05-04T15:11:44+00:00 http://oldabcuro.golins.com/abcuro_pubs/impact-of-anti-cytosolic-nucleotidase-1a-antibody-status-on-disease-phenotype-and-therapeutic-response-to-ulviprubart-in-inclusion-body-myositis/ 2026-06-08T21:42:37+00:00